AGFA HealthCare
MORTSEL, BELGIUM / ACCESSWIRE / May 14, 2024 / AGFA HealthCare is pleased to announce that St. Vincent's Private Hospital in Dublin, Ireland, has chosen to implement AGFA HealthCare's Enterprise Imaging. This five-year agreement includes Enterprise Imaging for both Radiology and Breast Imaging, structured and precision reporting modules, Best in KLAS XERO® Universal Viewer, AGFA's Scheduling solution, Business Intelligence, Patients and Clinician portal, and a Managed Services contract.
To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.Near-real-time image access
St. Vincent's Private Hospital is the largest acute private hospital in Dublin and part of the only integrated multi-hospital campus in Ireland. The Enterprise Imaging Platform will deliver the advanced capabilities and robust availability that the hospital needs.
"St. Vincent's Private Hospital is a unique healthcare environment. As we are on the same grounds as St. Vincent's University Hospital, we can share resources, expertise and medical facilities with this leading academic teaching establishment. This enables us to deal with a high volume of patients, often who have complex medical requirements. Imaging is core to this care. AGFA HealthCare's Enterprise Imaging will give us the reliable, robust platform that we need, whilst delivering very fast access to studies. Furthermore, AGFA HealthCare is able to support this system with managed services and monitoring that will maximise our uptime, while minimising the burden on our own resources," says Tim Aseervatham, Healthcare/Diagnostic Informatics Manager for St. Vincent's Private Hospital.
"We are proud of the trust that St. Vincent's Private Hospital - a key healthcare player in Ireland - is placing in AGFA HealthCare. This further demonstrates the success of our long-standing commitment to delivering solutions that improve the delivery of healthcare to patients in both the private and public healthcare sector in Ireland and beyond. Enterprise Imaging enables the creation of a secure, modular and scalable ecosystem, which helps the hospital to reduce complexity, improve clinical collaboration, and enhance workflow efficiency. By empowering all users to access imaging studies in near-real-time, it will allow them to focus on tasks that add value to both their patients' care and experience," says Colin Foley, Regional Business Manager for AGFA HealthCare Ireland.
Seamless care and collaboration
The Radiology Department at St. Vincent's Private Hospital is one of the largest radiology services in the country, offering a full range of diagnostic and interventional services. It performs over 65,000 studies every year, including X-ray, CT, mammography, MRI, ultrasound, fluoroscopy and DEXA. The department is made up of 18 consultant radiologists working in conjunction with highly qualified radiographers and nurses and supported by experienced administrators.
Enterprise Imaging will integrate with the hospital's existing pillar and patient referral systems and will replace all paper-based workflows. The five-year agreement includes:
- Enterprise Imaging for Radiology and Breast Imaging: a one-of-a-kind, seamless and secure platform designed to build a connected, collaborative, and scalable community of care. Enterprise Imaging delivers "life in flow" to meet radiologists' daily challenges through a highly focused, efficient and customisable experience.
- Best in KLAS XERO® Universal Viewer: provides patient-centric image access across the enterprise, with pixel streaming in near-real time on almost any device with no downloads or data moves, and enhanced viewing with clinical depth, collaboration and sharing, all on a single web viewer.
- Business Intelligence: enables easy-to-access reports and tools for gathering, organising, analysing and managing clinical, quality, financial and administrative data.
- Scheduling: facilitates managing appointments and orders for even the most complex imaging procedures in one easy and quick web-based application.
- Structured and precision reporting, including ACR BI-RADS® ATLAS and ACR PI-RADS® ATLAS: fully integrated in the Enterprise Imaging Platform, it combines customisation with automation to support clear communication and enhanced decision-making.
- Workflow orchestration: intelligently and automatically assigns tasks to radiologists, based on the chosen criteria.
- Collaboration tools: support multidisciplinary teams with the multimedia patient images they need, wherever they are, including at the point of care.
- Actionable findings notification: closes the loop between radiologists and clinicians through rapid and effective communication of incidental and critical imaging findings.
- Native 3D tools and advanced visualisation, plus seamlessly embedded third-party clinical application.
- Portal for patients and physicians: makes it easy for patients and physicians outside of the hospital to access medical images and results.
- Managed services and monitoring: support optimal maintenance and uptime of this flexible and high-performance solution.
We are delighted to welcome St Vincent's Hospital to #TeamAGFA and are honoured to add such a prestigious hospital to our customer base.
About AGFA HealthCare
At AGFA HealthCare, we are transforming the delivery of care - supporting healthcare professionals across the globe with secure, effective, and sustainable imaging data management. As a company, we are dedicated to our customers, and we have harnessed a value framework of Mission, Vision and Customer Delivery Principles into our routine operations. Through these principles, we commit a consistent high-yield code of conduct to our associates - channelling our experience and aspirations to all of our stakeholders. Our Empowerer profile supports our focus on creating an exceptional experience through the power of technology and is an integral foundation to our company standards. AGFA HealthCare is a division of the Agfa-Gevaert Group. For more information on AGFA HealthCare, please visit www.agfahealthcare.com and follow us on LinkedIn.
AGFA and the Agfa rhombus are registered trademarks of Agfa-Gevaert N.V. Belgium or its affiliates. XERO® is a registered trademark of AGFA HealthCare N.V., Belgium. BI-RADS and PI-RADS are registered trademarks of the American College of Radiology. All rights reserved. All information contained herein is intended for guidance purposes only, and the characteristics of the products and services described in this publication can be changed at any time without notice. Products and services may not be available for your local area. Please contact your local sales representative for availability information. AGFA HealthCare diligently strives to provide as accurate information as possible but shall not be responsible for any typographical error.
Contact Information
Buse Kayar
buse.kayar@issuerdirect.com
SOURCE: AGFA HealthCare
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference9.1.2026 18:35:00 CET | Press release
MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company's Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company's lead asset PRO CAR - 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level). About PromiCell, Inc. PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 T
Datavault AI Expands IBM Collaboration to Deploy Enterprise-Grade AI at the Edge with Available Infrastructure's SanQtum AI Platform8.1.2026 13:00:00 CET | Press release
Datavault AI will activate a secured multi-city edge AI network for real-time data tokenization, security, and monetization across New York and Philadelphia NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in instant data monetization & enterprise digital twins, announced it will deliver enterprise-grade AI performance at the edge in New York and Philadelphia through an expanded collaboration with IBM using the SanQtum AI platform. Operated by Available Infrastructure, SanQtum AI is a fleet of synchronized micro edge data centers running IBM's watsonx portfolio of AI products on a zero-trust network. The combined deployment is designed to enable cybersecure data storage and compute, real-time data scoring, tokenization, and ultra-low-latency, across two of the most data-dense metro regions in the United States. By running Datavault AI's Information Data Exchange and DataScore agents - built with watsonx - within SanQtum AI's zero-trust edge e
Ascend Advanced Therapies - ABL Inc. Further Strengthens Executive Team as It Drives Forward an Ambitious Growth Strategy8.1.2026 13:00:00 CET | Press release
Seiga Ohmine to join as Chief Commercial Officer, Sharad Dubey as Chief Financial Officer and Patrick Lansky as Senior Vice President of Global Business Development Appointments underscore Ascend-ABL's commitment to scientific rigor, operational excellence, and strategic growth ROCKVILLE, MARYLAND / ACCESS Newswire / January 8, 2026 / Ascend Advanced Therapies - ABL Inc. today announced significant appointments to its leadership team. Seiga Ohmine Ph.D. joins as Chief Commercial Officer (CCO) Sharad Dubey CA, CPA joins as Chief Financial Officer (CFO) Patrick Lansky joins as Senior Vice President of Global Business Development These appointments reflect Ascend-ABL's focus on strengthening scientific leadership, operational discipline, and customer-centric execution as the company sharpens its positioning as a trusted CDMO partner for advanced viral modalities. Commenting on the appointments, Alessandra Rispoli, Chief Executive Officer of Ascend-ABL said, "We are making strong progress
Market Logic Announces Technology Partnership with Zappi to Accelerate Innovation with AI8.1.2026 08:00:00 CET | Press release
BERLIN, DE / ACCESS Newswire / January 8, 2026 / Market Logic Software is excited to announce a technology partnership with Zappi designed to help leading brands develop, refine, and test new product concepts faster than ever before. United by a joint agentic AI framework, this collaboration brings together advanced AI capabilities from both companies, marking a pivotal shift in how organizations execute insights-driven innovation. Through AI-to-AI integrations, linking two powerful AI platforms, enterprises can now enrich their product innovation process with a comprehensive data ecosystem. Specially trained DeepSights AI agents within Market Logic's Innovation Studio continuously monitor, analyse, and synthesize market research, news, and operational data-allowing for accelerated concept generation and more informed decision-making. With just a couple of clicks, customers can seamlessly progress to testing their concepts with real people, thanks to Zappi's real-world respondent solut
RE Royalties Announces up to a USD $9.0 Million Portfolio-Level Royalty Investment with Solaris Energy Inc.7.1.2026 22:20:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / January 7, 2026 / RE Royalties Ltd. (TSXV:RE)(OTCQX:RROYF) ("RE Royalties" or the "Company") is pleased to announce that it has entered into a definitive agreement with Solaris Energy Inc. ("Solaris") to invest up to USD $9.0 million to acquire a royalty interest (the "Royalty Purchase") in two portfolios of distributed generation ("DG") solar projects located throughout the United States. The first portfolio consists of 15 projects including 9 under construction with several nearing operation, and 6 in development, located across California, Maine, Delaware, New Hampshire and Colorado ("Portfolio 1"). The second portfolio comprises 9 more projects, the final composition of which may evolve as the projects advance ("Portfolio 2"). The transaction represents the acquisition of a portfolio level royalty on a diversified portfolio of DG solar assets and marks the exciting beginning of a new partnership between the two parties. The Royalty Purchase for Por
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
